SCHEMBL7861905

SCHEMBL7861905

NCC1(CC(=O)O)C2CCCCC1CCCC2

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
CYP1A2 P05177 2/20 0.44
USP2 O75604 1/20 0.44
LMNA P02545 1/20 0.44
TSHR P16473 1/20 0.44
BLM P54132 1/20 0.44
CACNA2D1 P54289 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HSD11B1 P28845 7/20 0.38
CYP2D6 P10635 2/20 0.35
CYP3A4 P08684 1/20 0.35
POLB P06746 1/20 0.34
CYP2C19 P33261 1/20 0.33
GLRA1 P23415 1/20 0.31
SLC6A9 P48067 1/20 0.31
OR51E2 Q9H255 1/20 0.31
PEPD P12955 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27727 0.96 CYP1A2 (0.44) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL26519 0.91 CYP1A2 (0.42) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL7865257 0.78 HSD11B1 (0.56) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL14459065 0.78 HSD11B1 (0.56) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL5443318 0.75 CYP1A2 (0.39) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL5441518 0.75 CYP1A2 (0.39) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL7403691 0.75 CYP1A2 (0.39) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL5441916 0.75 CYP1A2 (0.39) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL5456118 0.75 CYP1A2 (0.39) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL5441921 0.75 CYP1A2 (0.39) ALDH1A1CYP1A2USP2LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888285-B1 NOVEL BRIDGED CYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS WARNER LAMBERT CO (US) 2001-12-12 EP disclosed
US-6020370-A ANTIEPILEPIC AGENT, BRAIN DISORDERS, NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS, ANALGESICS WARNER-LAMBERT COMPANY (US) 2000-02-01 US disclosed